Publication | Closed Access

Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement

Medicinal ChemistryDietary SupplementPharmaceutical ScienceBiochemistryMedicineNatural SciencesNew ClassPharmacotherapyPhosphodiesterase-5 InhibitorDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery